Soltanmohammadi Behnoush, Jalali-Javaran Mokhtar, Rajabi-Memari Hamid, Mohebodini Mehdi
Department of Biotechnology and Plant Breeding, Faculty of Agriculture, Tarbiat Modares University, Tehran, IR Iran.
Department of Agronomy and Plant Breeding, Shahid Chamran University, Ahvaz, IR Iran.
Jundishapur J Nat Pharm Prod. 2014 Feb;9(1):9-15. doi: 10.17795/jjnpp-7779. Epub 2014 Feb 20.
Plants are among promising and suitable platform systems for production of recombinant biopharmaceutical proteins due to several features such as safety, no need for fermentation, inexpensive investment, and fast and easy scale-up. Human insulin is one of the most widely used medicines in the world. Up to now different expression systems including Escherichia coli, yeast and CHO have been exploited for producing recombinant human insulin and a variety of different recombinant insulin are extensively used.
This study reports on the transformation and expression of proinsulin gene in tomato plants for the first time in Iran.
This study reports the cloning, transformation and expression of proinsulin gene in tomato plants. Specific primers were designed and used for PCR amplification and cloning of the proinsulin gene in the plant expression vector pCAMBIA1304. The recombinant construct was transferred into Agrobacterium tumefaciens strain LBA4404, and used for Agrobacterium mediated stable transformation of tomato plants. Presence of the desired gene in transgenic lines was confirmed through colony PCR and sequencing. The expression of the protein in transgenic lines was confirmed by immunodot blot assay.
The presence of the proinsulin gene in the genomic DNA of transgenic tomato was confirmed by PCR. Also total protein of transgenic tomato was extracted and the expression of proinsulin was detected using dotblot assay.
This survey addresses the possibility of proinsulin gene transfer and expression in tomato transgenic lines. This study can be used as a basis for future researches to produce human proinsulin in tomato and other candidate plants.
由于具有安全性、无需发酵、投资成本低以及快速且易于扩大规模等多种特性,植物是生产重组生物制药蛋白的有前景且合适的平台系统之一。人胰岛素是世界上使用最广泛的药物之一。到目前为止,包括大肠杆菌、酵母和中国仓鼠卵巢细胞(CHO)在内的不同表达系统已被用于生产重组人胰岛素,并且多种不同的重组胰岛素被广泛使用。
本研究首次报道了胰岛素原基因在伊朗番茄植株中的转化和表达情况。
本研究报道了胰岛素原基因在番茄植株中的克隆、转化和表达。设计了特异性引物并用于在植物表达载体pCAMBIA1304中进行胰岛素原基因的PCR扩增和克隆。将重组构建体转入根癌农杆菌菌株LBA4404,并用于农杆菌介导的番茄植株稳定转化。通过菌落PCR和测序确认转基因株系中存在所需基因。通过免疫斑点印迹分析确认转基因株系中蛋白质的表达。
通过PCR证实转基因番茄基因组DNA中存在胰岛素原基因。还提取了转基因番茄的总蛋白,并使用斑点印迹分析检测了胰岛素原的表达。
本研究探讨了胰岛素原基因在番茄转基因株系中转移和表达的可能性。本研究可为未来在番茄和其他候选植物中生产人胰岛素原的研究提供基础。